Comparison of the absolute CAPN5 abundance with the enrichment from the CD81 IP (Fig 5B) suggests that a large fraction of CAPN5 is associated with CD81 in human hepatoma cells. Here, CAPN5 is linked to hepatocellular carcinoma.